Completed PHASE1 INTERVENTIONAL 2-arm NCT03704675

Effect of Food on the Pharmacokinetics of TEW-7197 in Healthy Subjects

Clinical Trial for the Safety, Tolerability, and Pharmacokinetics of TEW-7197 Under Fed or Fasting in Healthy Male Subjects

Sponsor: MedPacto, Inc.

Conditions Healthy Volunteers

Interventions TEW-7197

Updated 6 times since 2018 Last updated: Apr 10, 2020 Started: Aug 8, 2018 Primary completion: Sep 9, 2018 Completion: Oct 20, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03704675, this PHASE1 trial focuses on Healthy Volunteers and remains completed. Sponsored by MedPacto, Inc., it has been updated 6 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE1
Sep 2024 — Sep 2025 [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
May 2020 — Jan 2021 [monthly]

Completed PHASE1

Status: Active Not Recruiting → Completed

▶ Show 1 earlier version

Nov 2018 — May 2020 [monthly]

Active Not Recruiting PHASE1

First recorded

Aug 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

MedPacto, Inc.

Data source: MedPacto, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Busan, South Korea